CAR-T cell therapy clinical trials provide more hope for lymphoma and leukaemia patients

Dr Michael Dickinson is the Lead of the Aggressive Lymphoma disease group within Clinical Haematology at Peter MacCallum Cancer Centre and Royal Melbourne Hospital. Michael has been instrumental in treating patients with chimeric antigen receptor T (CAR-T) cell therapy nationally. As Snowdome supported Michael for several years as the Peter MacCallum Cancer Centre Clinician Researcher … Continued

Miriam Dexter steps down as CEO after eight successful years

The Snowdome Board are sad to announce that after 8 successful years as the CEO of the Snowdome Foundation, Miriam Dexter has decided it is time to move on and spend more time with her family. “We will forever be grateful for all of Miriam’s efforts in leading our organisation to significant and sustained growth. … Continued

Snowdome Foundation welcomes John Salvaris as its new Board Chair

In December 2019 the Snowdome Chair, Roger Greenman AM, announced to the Board that 2020 would be his 6th and final year at the helm of Snowdome, before retiring. On behalf of Australian Blood Cancer patients, the Board would like to thank Roger for his dedicated service to our mission, which has seen Snowdome’s impact … Continued

July 30th COVID 19 Update by Prof Miles Prince AM

Victoria has been in lockdown for 3 weeks and new COVID 19 cases don’t seem to be slowing.  What does all this mean to us as a community and those of us living with a blood cancer? https://youtu.be/qFCfDhnb038

CAR-T cell treatment for multiple myeloma – the landscape so far

Chimeric Antigen Receptor (CAR) T cell therapy has been approved in Australia for forms of leukaemia and lymphoma for a while now, but we are still awaiting adequate evidence that CAR-T cell therapy works effectively in myeloma. CAR-T cell therapy genetically modifies T-cells to hunt out and find a protein (CD19) that is found on … Continued

Improving treatment outcomes for Australian myeloma patients

Dr Kylee Maclachlan moved her career and her family to New York City in August last year to help improve outcomes for Australian myeloma patients.  Kylee is aiming to establish an ongoing collaboration between the Peter MacCallum Cancer Centre and the Memorial Sloan Kettering Cancer Centre to share clinical trials, treatment protocols and expert knowledge. … Continued

Cancer blood test a lifesaving breakthrough

The Australian featured an exclusive story on the remarkable insights provided by genomic testing.  To quote Dr Piers Blombery, Head of the Molecular Haematology Laboratory at the Peter MacCallum Cancer Centre,“Every cancer is different and genomics testing such as the ctDNA panel gives clinicians more details about what drives the individual patient’s tumour cells; it … Continued

What have we learned about COVID 19 – Prof Prince enlightens us

We have been living with the COVID 19 pandemic for 6 months now.  Our knowledge about the virus and who is most at risk has grown dramatically.  Prof Miles Prince shares with us key learnings, what your risks are as a blood cancer patient and how to prepare should someone you live with get diagnosed. … Continued